ONKO ILAC VE TIC A.S.

ONKO ILAC VE TIC A.S. is a manufacturer (factory).

Company Introduction:

ONKO ILAC VE TIC A.S. is a Turkish pharmaceutical company primarily engaged in the research, development, manufacturing, and marketing of pharmaceutical products. The company focuses on contributing to human health by providing innovative and high-quality medicines. While their name includes "Ticaret" (Trade), their core operations involve the production of pharmaceutical formulations, particularly in specialized therapeutic areas such as oncology. They operate their own production facilities and are involved in the entire lifecycle of pharmaceutical products, from development to distribution.

ONKO ILAC VE TIC A.S. manufactures or sells products primarily in the fields of oncology, hematology, and rare diseases. Their product portfolio includes:

Oncology Drugs

Chemotherapy agents such as Pemetrexed, Docetaxel, and Oxaliplatin.

Targeted therapies including Erlotinib, Imatinib, and Lenalidomide.

Immunotherapies.

Biosimilars for cancer treatment, for example, Trastuzumab, Bevacizumab, Rituximab, Filgrastim, and Pegfilgrastim.

Hematology Drugs

Treatments for various hematological malignancies and blood disorders.

Supportive Care Products

Medications designed to manage the side effects of cancer treatment.

This includes growth factors, antiemetics, and pain management solutions.

Rare Disease Treatments

Specific therapies developed for orphan diseases.